Investor Hub

Novavax is a global biotechnology company with a proven vaccine technology. We are focused on developing our R&D assets and establishing partnerships to leverage the value of our technology to help protect health.

Latest quarterly earnings
Latest investor presentation
Latest clinical presentation
Annual report
Latest publications
NASDAQ:NVAX
Loading data...
Our ESG Approach

Discover the steps we have taken in the areas of access, governance, environment, and diversity and find our latest sustainability reports.

one hand holding a tree and one hand holding a globe
Get notifications for investor updates

Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings and more.

Shareholders seeking information can contact investor relations at (240) 268-2022 or contact us

Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.